Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. https://doi.org/10.1038/s41572-021-00284-z.

Article  PubMed  Google Scholar 

Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8(11):2211–25. https://doi.org/10.1016/j.ekir.2023.08.031.

Article  PubMed  PubMed Central  Google Scholar 

Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam, pharmacotherapy. J Hum Pharmacol Drug Ther. 2014;34(7):670–6. https://doi.org/10.1002/phar.1442.

Article  CAS  Google Scholar 

Gomes DM, Smotherman C, Birch A, et al. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014;34(7):662–9. https://doi.org/10.1002/phar.1428.

Article  CAS  PubMed  Google Scholar 

Meaney CJ, Hynicka LM, Tsoukleris MG. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy. 2014;34(7):653–61. https://doi.org/10.1002/phar.1423.

Article  CAS  PubMed  Google Scholar 

Greenwood D. Microbiological properties of teicoplanin. J Antimicrob Chemother. 1988;21(suppl A):1–13. https://doi.org/10.1093/jac/21.suppl_A.1.

Article  PubMed  Google Scholar 

Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother. 2009;53(10):4069–79. https://doi.org/10.1128/AAC.00341-09.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wood MJ. Comparative safety of teicoplanin and vancomycin. J Chemother. 2000;12(suppl 5):21–5. https://doi.org/10.1080/1120009X.2000.11782314.

Article  PubMed  Google Scholar 

Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Cochrane. 2009. https://doi.org/10.1002/9780470712184.

Article  Google Scholar 

Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https://doi.org/10.1136/bmj.n160.

Article  PubMed  PubMed Central  Google Scholar 

Kellum JA, Lameire N, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012. https://doi.org/10.1038/kisup.2012.1.

Article  Google Scholar 

Bellomo R, Ronco C, Kellum JA, Acute Dialysis Quality Initiative Workgroup, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–12. https://doi.org/10.1186/cc2872.

Article  PubMed  PubMed Central  Google Scholar 

Aslan AT, Pashayev T, Dağ O, Akova M. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury. Eur J Clin Microbiol Infect Dis. 2021;40(9):1953–61. https://doi.org/10.1007/s10096-021-04258-7.

Article  CAS  PubMed  Google Scholar 

Aslan AT, Kara E, Koksal G, et al. Comparison of piperacillin–tazobactam and vancomycin (TZP–VAN) with piperacillin–tazobactam and teicoplanin (TZP–TEI) for the risk of acute kidney injury (CONCOMITANT): a prospective observational, multinational, multi-centre cohort study. Int J Antimicrob Agents. 2025;65(3):107446. https://doi.org/10.1016/j.ijantimicag.2025.107446.

Article  CAS  PubMed  Google Scholar 

Oda K, Hashiguchi Y, Katanoda T, et al. Lowered risk of nephrotoxicity through intervention against the combined use of vancomycin and tazobactam/piperacillin: a retrospective cohort study. Microbiol Spectr. 2021;9(1):e0035521. https://doi.org/10.1128/Spectrum.00355-21.

Article  PubMed  Google Scholar 

Sazanami K, Inose R, Yagi T, et al. Incidence of acute kidney injury after teicoplanin– or vancomycin– and piperacillin/tazobactam combination therapy: a comparative study using propensity score matching analysis. J Infect Chemother. 2021;27(12):1723–8. https://doi.org/10.1016/j.jiac.2021.08.012.

Article  CAS  PubMed  Google Scholar 

Shao C-H, Tai C-H, Lin F-J, et al. Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam. J Formos Med Assoc. 2021;121(1):117–25. https://doi.org/10.1016/j.jfma.2021.02.004.

Article  CAS  PubMed  Google Scholar 

Wada F, Yasuyuki A, Tomoyasu J, et al. Impact of antimicrobial drug-drug interactions on acute kidney injury after allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2023;29(10):634.e1-634.e7. https://doi.org/10.1016/j.jtct.2023.07.017.

Article  CAS  PubMed  Google Scholar 

Peterson J, Welch V, Losos M, Tugwell PJOOHRI (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute, 2(1):1-12.

Aslan AT, Akova M. Piperacillin–tazobactam plus vancomycin-associated acute kidney injury in adults: can teicoplanin or other antipseudomonal beta-lactams be remedies? Healthcare. 2022;10(8):1582. https://doi.org/10.3390/healthcare10081582.

Article  PubMed  PubMed Central  Google Scholar 

Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect. 2020;26(6):696–705. https://doi.org/10.1016/j.cmi.2020.03.019.

Article  CAS  PubMed  Google Scholar 

Alshehri AM, Alzahrani MY, Abujamal MA, et al. Comparative risk of acute kidney injury following concurrent administration of vancomycin with piperacillin/tazobactam or meropenem: a systematic review and meta-analysis of observational studies. Antibiotics. 2022;11(4):526. https://doi.org/10.3390/antibiotics11040526.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciarambino T, Giannico OV, Campaninle A, et al. Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review. Intern Emerg Med. 2020;15(2):327–31. https://doi.org/10.1007/s11739-020-02287-2.

Article  PubMed  Google Scholar 

Alaradi L, Albariqi N, Alanazi M, et al. Incidence of acute kidney injury (AKI) in critically ill patients receiving concomitant vancomycin with piperacillin-tazobactam or cefepime; a systemic review and meta-analysis. J Intensive Care Med. 2025. https://doi.org/10.1177/08850666251323265.

Article  PubMed  Google Scholar 

Karino S, Kaye KS, Navalkele B, et al. Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: opportunities for antimicrobial stewardship. Antimicrob Agents Chemother. 2016;60(6):3743–50. https://doi.org/10.1128/AAC.03011-15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng Y, Ye X, Li Y, et al. Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials. PLoS ONE. 2013;8(11):e79782. https://doi.org/10.1371/journal.pone.0079782.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanai Y, Takashi Y, Niwa T, et al. Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: a systematic review and meta-analysis. J Clin Pharm Ther. 2021;46(3):622–32. https://doi.org/10.1111/jcpt.13366.

Article  CAS  PubMed  Google Scholar 

European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Targocid Art 30—CHMP Opinion, Summary of Product Characteristics, Labelling and Package Leaflet. 2021.

Bugano DDG, Cavalcanti AB, Goncalves AR, et al. Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection. Einstein (São Paulo). 2011;9(3):265–82. https://doi.org/10.1590/s1679-45082011ao2020.

Article  PubMed  Google Scholar 

Cartin-Ceba R, Kashiouris M, Plataki M, et al. Risk factors for development of acute kidney injury in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Res Pract. 2012;2012:691013. https://doi.org/10.1155/2012/691013.

Article  PubMed  PubMed Central